Frank Jaehnert
Analyst · Tony Kure of KeyBanc
Good morning, and thank you for joining us. I'm pleased with our performance in this quarter, as our business in the Americas and in Asia Pacific showed improved results over last quarter. In Asia, in particular, we benefited from several new product wins in the mobile handset and tablet computer space. Market conditions remain challenging in Europe, resulting in organic revenue decline. We are shifting our resources to the highest growth opportunities in the EMEA, which includes expanding our business in Central Europe, the Middle East and Africa. This is somewhat mitigating the impact of the difficult macroeconomic conditions in Western Europe.
In the Americas, we continue to see positive growth in our U.S. identification solutions business, but the macroeconomic weakness in Brazil offset this positive growth. We are also pruning our portfolio of businesses where we do not see a clear path to sustainable organic growth and satisfactory profitability. For instance, in October, we sold Varitronics, a business located in Minnesota serving the education market, with annual sales of about $15 million. In August, we sold Brady Medical, our medical die-cut business in Texas, with annual sales of approximately $18 million. Together, these businesses had approximately breakeven earnings in fiscal 2012.
Looking broadly, the global economy is sluggish at best, with pockets of weakness. As such, in order to create growth, we are focused on the following initiatives: expanding our business in emerging geographies or geographies where we are under-penetrated; second, expanding globally in certain focused markets such as aerospace and mass transit, chemical, oil and gas, and food and beverage processing; third, new product development; fourth, commitment to customer conversion; and five, expansion of our digital capabilities to deliver the best online buying experience for our customers. We continue to look for acquisitions as a use of cash as we are committed to making acquisitions at the right price, investing in organic growth opportunities at the top long-term uses of our cash.
Now I'd like to turn the call over to Tom Felmer for our financial review. Tom?